Click for St. Louis, Missouri Forecast

// a href = ./ // St Louis News, Weather, Sports, The Big 550 AM, St Louis Traffic, Breaking News in St Louis

Online pharmacy:fesmag.com/tem

Have you a sex problem? Please visit our site:fesmag.com/medic

 
 
 

Doctors: Too few cancer patients enroll in studies

Rate this item
(0 votes)
One of every 10 clinical trials for adults with cancer ends prematurely because researchers can't get enough people to test new treatments, scientists report.
 
The surprisingly high rate reveals not just the scope and cost of wasted opportunities that deprive patients of potential advances, but also the extent of barriers such as money, logistics and even the mistaken fear that people won't get the best care if they join one of these experiments.
 
"Clinical trials are the cornerstone of progress in cancer care," the way that new treatments prove their worth, said Dr. Matthew Galsky of the Icahn School of Medicine at Mount Sinai Hospital in New York.
 
When an experimental drug or other treatment fails to make it to the market, people often think it didn't work or had too many side effects, but the inability to complete studies can doom a drug, too, Galsky said.
 
He helped lead an analysis of 7,776 experiments registered on Clinicaltrials.gov, a government web site for tracking medical experiments, from September 2005 to November 2011. All were mid- or late-stage studies testing treatments for various types of cancer in adults.
 
About 20 percent of the studies were not completed for reasons that had nothing to do with the treatment's safety or effectiveness (legitimate reasons for ending a study early). Poor accrual — the inability to enroll enough patients in enough time to finish the study — led to nearly 40 percent of premature endings.
 
Company-sponsored studies were less likely to be completed than those sponsored by the government or others. Late-stage cancer trials can cost companies "tens to even hundreds of millions of dollars," and that money is wasted if no clear answer on the drug's value is gained, said Dr. Charles J. Ryan, a cancer specialist at the University of California, San Francisco.
 
He heads the program for a conference later this week in San Francisco where Galsky's study will be presented. It was discussed Tuesday in a telebriefing by the American Society of Clinical Oncology, an organization for doctors who treat cancer.
 
Ryan and Galsky said they hoped the study would spur more research on why more patients don't participate. In most cases, the treatment being tested is provided for free, but there can be other costs such as lab tests. Some states require insurers to cover these additional costs, but others do not, so money may be one hurdle for patients.
 
Some doctors do not strongly encourage patients to participate in studies, and sometimes patients fear they'll get a dummy treatment instead of real medicine. However, in cancer clinical trials, ethical standards require that all patients get the current best care, plus a chance at an experimental treatment.
 
"Patients still have concerns about getting a placebo, but they're always going to get at a minimum the standard of care," said Shelley Fuld Nasso, head of the National Coalition for Cancer Survivorship, a patient advocacy and education organization.
 
Doctors need to encourage more patients to participate, and clinical trial designers need to make sure they are testing key questions and treatments to honor the contributions of study participants, she said.
 
___
 
Online:
 
Cancer patient info: http://www.cancer.net
 
Decision-making guide: http://bit.ly/L67zkT
 
Clinical trials: http://www.clinicaltrials.gov
 

Latest News

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
Prev Next
DECONTAMINATING PATIENTS CUTS HOSPITAL INFECTIONS

DECONTAMINATING PATIENTS CUTS HOSPITAL INFECTIONS

CHICAGO (AP) -- Infections in U.S. hospitals kill tens of thousands of people each year, and many institutions fight back by screening new patients to see if they carry a dangerous...

CATHOLIC HOSPITAL TAKES SURPRISE STANCE IN LAWSUIT

CATHOLIC HOSPITAL TAKES SURPRISE STANCE IN LAWSUIT

DENVER (AP) -- It was a startling assertion that seemed an about-face from church doctrine: A Catholic hospital arguing in a Colorado court that twin fetuses that died in its care ...

Report finds lax oversight of specialty pharmacies

Report finds lax oversight of specialty pharmacies

   WASHINGTON (AP) - A congressional investigation finds that specialty pharmacies like the one that triggered a deadly meningitis outbreak last year have little state oversight. ...

Study ties chemical to possible miscarriage risk

Study ties chemical to possible miscarriage risk

   BOSTON (AP) — New research suggests that high levels of BPA, a chemical in many plastics and canned food linings, might raise the risk of miscarriage in women prone to that prob...

NEW WHOOPING COUGH STRAIN IN US RAISES QUESTIONS

NEW YORK (AP) -- Researchers have discovered the first U.S. cases of whooping cough caused by a germ that may be resistant to the vaccine. Health officials are looking into whet...

ALZHEIMER'S BUDDY PROGRAM PAIRS PATIENTS, STUDENTS

ALZHEIMER'S BUDDY PROGRAM PAIRS PATIENTS, STUDENTS

CHICAGO (AP) -- At age 80, retired Chicago physician and educator Dan Winship is getting a bittersweet last chance to teach about medicine - only this time he's the subject. In ...

© 2013 KTRS All Rights Reserved